Thomas R. Insel | Academic Influence

Thomas R. Insel's AcademicInfluence.com Rankings

Thomas R. Insel

Biology

#821

World Rank

#1425

Historical Rank

#438

USA Rank

Neuroscience

#97

World Rank

#102

Historical Rank

#42

USA Rank

biology Degrees

Download Badge

Biology

Thomas R. Insel's Degrees

Masters Medicine Boston University

Why Is Thomas R. Insel Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Thomas Roland Insel is an American neuroscientist, psychiatrist, entrepreneur, and author who led the National Institute of Mental Health from 2002 until November 2015. Prior to becoming Director of NIMH, he was the founding Director of the Center for Behavioral Neuroscience at Emory University in Atlanta, Georgia. He is best known for research on oxytocin and vasopressin, two peptide hormones implicated in complex social behaviors, such as parental care and attachment. He announced on Sept. 15, 2015, that he was resigning as the director of the NIMH to join the Life Science division of Google X . On May 8, 2017, CNBC reported that he had left Verily Life Sciences. Insel is a Co-founder with Richard Klausner and Paul Dagum of a digital mental health company named "Mindstrong," a Bay-area startup. He has also co-founded Humanest Care, NeuraWell Therapeutics, and MindSite News and is a member of the scientific advisory board for Compass Pathways, a company that is developing the psychedelic drug psilocybin to treat depression and other mental health disorders. His book, Healing: Our Path from Mental Illness to Mental Health was published by Penguin Random House in February, 2022.

(See a Problem?)

Thomas R. Insel's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Genotype-Tissue Expression (GTEx) project (2013) (6030)
Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. (2010) (5078)
Toward the future of psychiatric diagnosis: the seven pillars of RDoC (2013) (2177)
Grand challenges in global mental health (2011) (1723)
Rethinking schizophrenia (2010) (1290)
The NIMH Research Domain Criteria (RDoC) Project: precision medicine for psychiatry. (2014) (1142)
The neurobiology of attachment (2001) (1067)
Social amnesia in mice lacking the oxytocin gene (2000) (1014)
Oxytocin in the Medial Amygdala is Essential for Social Recognition in the Mouse (2001) (969)
The Challenge of Translation in Social Neuroscience: A Review of Oxytocin, Vasopressin, and Affiliative Behavior (2010) (919)
A role for central vasopressin in pair bonding in monogamous prairie voles (1993) (906)
Early Life Programming and Neurodevelopmental Disorders (2010) (826)
Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. (1996) (660)
The Neurobiology of Parental Behavior (2003) (587)
The Knockout Mouse Project (2004) (574)
The Neuroendocrine Basis of Social Recognition (2002) (532)
Brain disorders? Precisely (2015) (525)
Oxytocin Receptor Distribution Reflects Social Organization in Monogamous and Polygamous Voles (1992) (518)
How the brain processes social information: searching for the social brain. (2004) (515)
Assessing the economic costs of serious mental illness. (2008) (499)
A neurobiological basis of social attachment. (1997) (488)
Increased affiliative response to vasopressin in mice expressing the V1a receptor from a monogamous vole (1999) (477)
Oxytocin Administered Centrally Facilitates Formation of a Partner Preference in Female Prairie Voles (Microtus ochrogaster) (1994) (473)
Digital Phenotyping: Technology for a New Science of Behavior. (2017) (465)
Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. (2009) (461)
Oxytocin — A neuropeptide for affiliation: Evidence from behavioral, receptor autoradiographic, and comparative studies (1992) (459)
Cellular Mechanisms of Social Attachment (2001) (457)
A gender-specific mechanism for pair bonding: oxytocin and partner preference formation in monogamous voles. (1995) (437)
Toward a neuroanatomy of obsessive-compulsive disorder. (1992) (437)
Distribution of Corticosteroid Receptors in the Rhesus Brain: Relative Absence of Glucocorticoid Receptors in the Hippocampal Formation (2000) (422)
Is social attachment an addictive disorder? (2003) (421)
Nucleus accumbens dopamine differentially mediates the formation and maintenance of monogamous pair bonds (2006) (412)
Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology (1987) (398)
The primate neocortex in comparative perspective using magnetic resonance imaging. (1999) (390)
Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls. (1987) (364)
Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. (1983) (355)
Oxytocin receptor distribution reflects social organization in monogamous and polygamous voles. (1992) (355)
Infant Vocalization, Adult Aggression, and Fear Behavior of an Oxytocin Null Mutant Mouse (2000) (354)
Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. (2010) (331)
Obsessive-compulsive disorder and serotonin: Is there a connection? (1985) (327)
Epigenetic sources of behavioral differences in mice (2003) (322)
NIH Molecular Libraries Initiative (2004) (318)
New models of collaboration in genome-wide association studies: the Genetic Association Information Network (2007) (313)
Dopamine D2 receptors in the nucleus accumbens are important for social attachment in female prairie voles (Microtus ochrogaster). (2000) (310)
Rearing Effects on Cerebrospinal Fluid Oxytocin Concentration and Social Buffering in Rhesus Monkeys (2003) (309)
Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment. (1988) (300)
Autoradiographic and in situ hybridization localization of corticotropin‐releasing factor 1 and 2 receptors in nonhuman primate brain (1999) (297)
A Neurodevelopmental Perspective on the Research Domain Criteria (RDoC) Framework (2014) (292)
The social deficits of the oxytocin knockout mouse (2002) (292)
Obsessive-compulsive disorder with psychotic features: a phenomenologic analysis. (1986) (291)
Facilitation of Affiliation and Pair-Bond Formation by Vasopressin Receptor Gene Transfer into the Ventral Forebrain of a Monogamous Vole (2001) (289)
The NIH BRAIN Initiative (2013) (282)
Subcortical projections of area 25 (subgenual cortex) of the macaque monkey (2000) (276)
Psychiatry as a clinical neuroscience discipline. (2005) (273)
Neuroendocrine bases of monogamy (1998) (255)
Neuropeptides and the evolution of social behavior (2000) (253)
Endophenotypes: Bridging Genomic Complexity and Disorder Heterogeneity (2009) (252)
Oxytocin, vasopressin, and autism: is there a connection? (1999) (251)
Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism (2002) (250)
Enhanced social interactions in rats following chronic, centrally infused oxytocin (1992) (246)
Cure therapeutics and strategic prevention: raising the bar for mental health research (2006) (243)
Species differences in V1a receptor gene expression in monogamous and nonmonogamous voles: behavioral consequences. (1997) (234)
Oxytocin and Social Bonding a (1992) (233)
Lesions of the hypothalamic paraventricular nucleus disrupt the initiation of maternal behavior (1989) (219)
Rat pup ultrasonic isolation calls: Possible mediation by the benzodiazepine receptor complex (1986) (217)
The sleep of patients with obsessive-compulsive disorder. (1982) (207)
Mating in the monogamous male: Behavioral consequences (1995) (203)
The comparative distribution of forebrain receptors for neurohypophyseal peptides in monogamous and polygamous mice (1991) (196)
The ontogeny of excitatory amino acid receptors in the rat forebrain—II. Kainic acid receptors (1990) (193)
Dopamine D2 receptor-mediated regulation of partner preferences in female prairie voles (Microtus ochrogaster): a mechanism for pair bonding? (1999) (189)
Central administration of oxytocin modulates the infant rat's response to social isolation. (1991) (187)
A benzodiazepine receptor-mediated model of anxiety. Studies in nonhuman primates and clinical implications. (1984) (175)
Rethinking mental illness. (2010) (174)
Neurological and neuropsychological studies of patients with obsessive-compulsive disorder. (1983) (173)
Sexual and social experience is associated with different patterns of behavior and neural activation in male prairie voles (1997) (166)
Immunoreactivity of central vasopressin and oxytocin pathways in microtine rodents: A quantitative comparative study (1996) (161)
Grand Challenges in Global Mental Health: Integration in Research, Policy, and Practice (2013) (158)
Next-Generation Treatments for Mental Disorders (2012) (155)
Psychiatric epidemiology: it's not just about counting anymore. (2005) (152)
Oxytocin, vasopressin, and the neuroendocrine basis of pair bond formation. (1998) (151)
Disruptive insights in psychiatry: transforming a clinical discipline. (2009) (151)
Regional Changes in Brain Oxytocin Receptors Post‐Partum: Time‐Course and Relationship to Maternal Behaviour (1990) (150)
Differential expansion of neural projection systems in primate brain evolution. (1999) (146)
Changes in Oxytocin Receptor mRNA in Rat Brain During Pregnancy and the Effects of Estrogen and Interleukin‐6 (1997) (146)
Digital phenotyping: a global tool for psychiatry (2018) (144)
A selective oxytocin antagonist attenuates progesterone facilitation of female sexual behavior. (1991) (143)
National Institute of Mental Health clinical trials: new opportunities, new expectations. (2014) (141)
Partner Preference Development in Female Prairie Voles Is Facilitated by Mating or the Central Infusion of Oxytocin a (1992) (140)
Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action. (1989) (134)
Voles and vasopressin: a review of molecular, cellular, and behavioral studies of pair bonding and paternal behaviors. (1998) (130)
Limbic system fos expression associated with paternal behavior (1994) (129)
Central oxytocin and reproductive behaviours. (1997) (129)
Increased plasma MHPG in dexamethasone-resistant depressed patients. (1983) (127)
Research on major depression: strategies and priorities. (2003) (124)
Anxiety and cerebral blood flow during behavioral challenge. Dissociation of central from peripheral and subjective measures. (1989) (124)
Evolution of the Cerebellum in Primates: Differences in Relative Volume among Monkeys, Apes and Humans (1998) (124)
Increased Number of BrdU-Labeled Neurons in the Rostral Migratory Stream of the Estrous Prairie Vole (2001) (123)
Ontogeny of oxytocin receptors in rat forebrain: A quantitative study (1989) (122)
Infant's response to social separation reflects adult differences in affiliative behavior: a comparative developmental study in prairie and montane voles. (1990) (120)
The STAR*D trial: revealing the need for better treatments. (2009) (117)
Species differences in vasopressin receptor binding are evident early in development: Comparative anatomic studies in prairie and montane voles (1997) (117)
Oxytocin in maternal, sexual, and social behaviors. (1992) (117)
Toward a Neurobiology of Attachment (2000) (116)
Regional induction of c-fos-like protein in rat brain after estradiol administration. (1990) (116)
Possible development of the serotonin syndrome in man. (1982) (116)
The dexamethasone suppression test in patients with primary obsessive-compulsive disorder (1982) (115)
Optogenetics: 10 years after ChR2 in neurons—views from the community (2015) (112)
Postpartum increases in brain oxytocin binding. (1986) (111)
What are the long-term effects of methylphenidate treatment? (2003) (111)
The NIMH experimental medicine initiative (2015) (111)
Serotonin and neuropeptides in affiliative behaviors (1998) (106)
Innovative solutions to novel drug development in mental health (2013) (106)
Gene Targeting Approaches to Neuroendocrinology: Oxytocin, Maternal Behavior, and Affiliation (1997) (104)
The infant rat separation paradigm: a novel test for novel anxiolytics. (1991) (104)
Drug treatment of obsessive-compulsive disorder. (1987) (102)
Comparative neuroanatomy of the sexually dimorphic hypothalamus in monogamous and polygamous voles (1991) (102)
Species Differences in Central Oxytocin Receptor Gene Expression: Comparative Analysis of Promoter Sequences (1996) (102)
Beyond efficacy: the STAR*D trial. (2006) (98)
Neuroendocrine basis of social recognition (2004) (97)
Effects of central vasopressin administration to infant rats. (1993) (96)
Axon-sparing lesions of the medial nucleus of the amygdala decrease affiliative behaviors in the prairie vole (Microtus ochrogaster): behavioral and anatomical specificity. (1994) (96)
Increased accumulation of oxytocin messenger ribonucleic acid in the hypothalamus of the female rat: induction by long term estradiol and progesterone administration and subsequent progesterone withdrawal. (1995) (94)
The Data of Diagnosis: New Approaches to Psychiatric Classification (2010) (94)
From Animal Models to Model Animals (2007) (90)
Neurobiology of obsessive compulsive disorder. (1992) (88)
Rat pup isolation calls are reduced by functional antagonists of the NMDA receptor complex. (1990) (88)
Obsessive—Compulsive Disorder as a 5-HT Subsystem-Related Behavioural Disorder (1989) (87)
The Promise of Extinction Research for the Prevention and Treatment of Anxiety Disorders (2006) (87)
Prenatal stress has long-term effects on brain opiate receptors (1990) (86)
Infant rat separation is a sensitive test for novel anxiolytics (1991) (85)
Mental disorders in childhood: shifting the focus from behavioral symptoms to neurodevelopmental trajectories. (2014) (83)
Endogenous opioids: do they modulate the rat pup's response to social isolation? (1991) (82)
Data mining for health: staking out the ethical territory of digital phenotyping (2018) (80)
Time course of the estradiol-dependent induction of oxytocin receptor binding in the ventromedial hypothalamic nucleus of the rat. (1989) (78)
Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine. (1990) (78)
The AURORA Study: A Longitudinal, Multimodal Library of Brain Biology and Function after Traumatic Stress Exposure (2019) (78)
The arrival of preemptive psychiatry (2007) (77)
Psychiatry in the genomics era. (2003) (77)
Oxytocin and complex social behavior: species comparisons. (1993) (77)
Oxytocin Receptors and Maternal Behavior (1992) (77)
Growth Hormone Response to Clonidine in Obsessive-Compulsive Patients (1983) (76)
Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys. (1984) (76)
Twenty-Five Years of Progress: The View from NIMH and NINDS (2013) (76)
Naloxone administration in obsessive-compulsive disorder: report of two cases. (1983) (75)
The regulation of oxytocin receptor binding in the ventromedial hypothalamic nucleus by testosterone and its metabolites. (1991) (74)
Central administration of corticotropin releasing factor alters rat pup isolation calls (1989) (72)
Families of Origin in Obsessive‐Compulsive Disorder (1984) (71)
The psychopharmacological treatment of obsessive-compulsive disorder: a review. (1981) (71)
Parents of patients with obsessive-compulsive disorder (1983) (69)
The ability of oxytocin to induce short latency maternal behavior is dependent on peripheral anosmia. (1987) (67)
Drug research: A plan for mental illness (2012) (66)
Pharmacologic models of anxiety. (1983) (65)
Pharmacogenomics and Personalized Medicine in Neuropsychiatry (2012) (64)
Eating disorders: National Institute of Mental Health's perspective. (2007) (63)
Faulty circuits. (2010) (62)
An iodinated vasopressin (V1) antagonist blocks flank marking and selectively labels neural binding sites in golden hamsters (1993) (62)
Vasopressin in the forebrain of common marmosets (Callithrix jacchus): studies with in situ hybridization, immunocytochemistry and receptor autoradiography (1997) (62)
The NIH Toolbox (2013) (62)
Cytoplasmic oxytocin and vasopressin gene transcripts decline postpartum in the hypothalamus of the lactating rat. (1993) (61)
Expression and estrogen regulation of brain‐derived neurotrophic factor gene and protein in the forebrain of female prairie voles (2001) (61)
Homologous regulation of brain oxytocin receptors. (1992) (61)
Oxytocin: who needs it? (2001) (60)
Vasopressin and oxytocin immunoreactive neurons and fibers in the forebrain of male and female common marmosets (Callithrix jacchus) (1997) (60)
Effect of gonadal steroids upon hypothalamic oxytocin expression. (1995) (59)
Oxytocin and the molecular basis of monogamy. (1995) (58)
Oxytocin and maternal behavior (1990) (57)
Reducing the burden of suicide in the U.S.: the aspirational research goals of the National Action Alliance for Suicide Prevention Research Prioritization Task Force. (2014) (57)
Differential regulation of corticotropin-releasing factor receptors in anterior and intermediate lobes of pituitary and in brain following adrenalectomy in rats (1985) (57)
Neurotoxic Effects of MDMA on Brain Serotonin Neurons: Evidence from Neurochemical and Radioligand Binding Studies a (1990) (51)
Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtype-selective agonists and antagonists (2005) (50)
D-Amphetamine in obsessive-compulsive disorder (2004) (49)
Molecular Aspects of Monogamy (1997) (49)
Biological markers in obsessive-compulsive and affective disorders. (1984) (46)
Phenomenology of obsessive compulsive disorder. (1990) (45)
Translating Oxytocin Neuroscience to the Clinic: A National Institute of Mental Health Perspective (2016) (45)
Vaginocervical Stimulation Releases Oxytocin within the Spinal Cord in Rats (2002) (44)
Rat Pup Ultrasonic Vocalizations: An Ethologically Relevant Behaviour Responsive to Anxiolytics (1991) (43)
CRH and α-helical-CRH modulate behavioral measures of arousal in monkeys (1989) (42)
The role of neurohypophyseal peptides in the central mediation of complex social processes — evidence from comparative studies (1993) (42)
Parental Behavior in Voles (1996) (41)
A Primate Genome Project Deserves High Priority (2000) (41)
Muscarinic cholinergic influences on ACTH and β-endorphin release mechanisms in human subjects (1981) (40)
Deep Brain Stimulation in Psychiatry: Concentrating on the Road Ahead (2009) (38)
Binding sites for corticotropin releasing factor in sensory areas of the rat hindbrain and spinal cord (1985) (37)
Dexamethasone fails to suppress beta-endorphin plasma concentrations in humans and rhesus monkeys. (1980) (37)
Vasopressin modulates male squirrel monkeys' behavior during social separation. (1991) (36)
The dexamethasone suppression test: promises and problems of diagnostic laboratory tests in psychiatry. (1983) (36)
Noradrenergic challenges in the affective disorders. (1981) (36)
Limits to growth: why neuroscience needs large-scale science (2004) (36)
Breaking the log-jam in treatment development for cognition in schizophrenia: NIMH perspective (2003) (35)
Testosterone modulates oxytocin binding in the hypothalamus of castrated male rats. (1989) (35)
Infant separation distress in genetically fearful rats (1987) (35)
Serotonergic and catecholaminergic reuptake inhibitors have opposite effects on the ultrasonic isolation calls of rat pups. (1990) (35)
Neurobiology of social attachment (2011) (34)
Depression and comorbid medical illness: the National Institute of Mental Health perspective (2003) (34)
Changes in mu opiate receptors following inescapable shock (1989) (33)
Digital Technologies in Psychiatry: Present and Future. (2018) (33)
Growth hormone response to clonidine unchanged by chronic clorgyline treatment (1982) (33)
Effects of chlordiazepoxide and beta-carboline 3-carboxylic acid ethyl ester on non-suppressed and minimally-suppressed responding in the squirrel monkey. (1992) (32)
Mouse models for autism: report from a meeting (2001) (31)
Plasma cortisol and catecholamine responses to intracerebroventricular administration of CRF to rhesus monkeys. (1984) (31)
Plasma steady‐state concentrations of hydroxylated metabolites of clomipramine (1982) (30)
Psychiatry Residency Training, the Physician-Scientist, and the Future of Psychiatry (2004) (30)
Therapeutic responses to tricyclic antidepressants and related drugs in non-affective disorder patient populations (1985) (30)
Obsessive-compulsive disorder. (1985) (29)
S.24.01 The development of brain and behavior (1996) (29)
Rebooting for Whom? (2011) (28)
A novel chemically induced animal model of human anxiety. (1984) (27)
Tyrosine hydroxylase cofactor (tetrahydrobiopterin) in parkinsonism. (1984) (26)
Obsessive compulsive disorder-five clinical questions and a suggested approach. (1982) (26)
Neuroscience Networks (2003) (24)
Mind the Gap: Neuroscience Literacy and the Next Generation of Psychiatrists (2014) (23)
Translating Discoveries into Medicine: Psychiatric Drug Development in 2011 (2012) (23)
Obsessive-compulsive disorder: a neuroethological perspective. (1988) (22)
Rat Pup Ultrasonic Isolation Calls and the Benzodiazepine Receptor (1988) (21)
Obsessive-compulsive disorder and alcoholism. (1986) (20)
Cognitive Neuroscience and Schizophrenia: Translational Research in Need of a Translator (2008) (20)
Psychophysiological Changes during Pharmacological Treatment of Patients with Obsessive Compulsive Disorder (1984) (19)
Oxytocin and the neurobiology of attachment (1992) (19)
Abducens palsy after lumbar puncture. (1980) (19)
Effect of long-term clorgyline administration on human platelet alpha-adrenergic receptor binding and platelet cyclic AMP responses (1983) (19)
CRH and alpha-helical-CRH modulate behavioral measures of arousal in monkeys. (1989) (18)
Neurobiology of obsessive compulsive disorder: a review (1992) (16)
Decreased in vivo binding to brain benzodiazepine receptors during social isolation (2004) (16)
Tetrahydrobiopterin administration to rhesus macaques. Its appearance in CSF and effect on neurotransmitter synthesis. (1986) (16)
NIMH-Funded Pragmatic Trials: Moving On (2010) (16)
Developmental psychobiology for public health: a bridge for translational research. (2005) (15)
Antiobsessional and antidepressant effects of clomipramine in the treatment of obsessive-compulsive disorder. (1982) (15)
Classification issues in women’s mental health: clinical utility and etiological mechanisms (2010) (15)
Preventing the onset of psychosis: not quite there yet. (2015) (15)
Tricyclic response in obsessive compulsive disorder (1985) (15)
Serotonin in Obsessive Compulsive Disorder (1990) (15)
Maximizing efficiency and impact in effectiveness and services research. (2010) (15)
Shining Light on Depression (2007) (14)
Benzodiazepine Receptor-Mediated “Anxiety” in Primates (1985) (14)
Obsessive Compulsive Disorder: Pharmacologic Approaches (1985) (14)
Social anxiety: from laboratory studies to clinical practice (2002) (14)
Eye-tracking, attention and amphetamine challenge. (1987) (12)
Diurnal variation in cerebrospinal fluid prolactin concentration of the rhesus monkey. (1981) (12)
A New Era in Psychiatric Genetics? (2007) (12)
Mouse maps of gene expression in the brain (2007) (12)
Preparing Physician-Scientists for an Evolving Research Ecosystem. (2018) (11)
A bridge to somewhere (2011) (11)
The conundrum of co-occurring mental and substance use disorders: Opportunities for research (2004) (11)
How algorithms could bring empathy back to medicine (2019) (10)
Future Directions: Setting Priorities to Guide the Federal Research Effort (2011) (10)
Are Glutamatergic Pathways Involved in the Pathophysiology of Anxiety (1991) (10)
The "Neuro" in Neurogenetics (2008) (10)
The dopamine system challenge in affective disorders: a review of behavioral and neuroendocrine responses. (1981) (10)
From Prevention to Preemption: A Paradigm Shift in Psychiatry (2008) (9)
Join the disruptors of health science (2017) (9)
Differential Fos Expression Following Microinjection of Oxytocin or Vasopressin in the Prairie Vole Brain (1997) (9)
Closed curves and geodesics with two self-intersections on the Punctured torus (1998) (9)
Bending the Curve for Mental Health: Technology for a Public Health Approach. (2019) (9)
Biological alterations in the primary affective disorders and other tricyclic-responsive disorders (1985) (9)
Neurobiology of obsessive compulsive disorder: a possible role for serotonin. (1990) (9)
Shedding Light on Brain Circuits (2012) (8)
Building the Thermometer for Mental Health (2018) (8)
Psychiatric Education in the Genomic Era (2010) (8)
Tetrahydrobiopterin administration to rhesus macaques (1986) (8)
Drug Effects on Primate Alarm Vocalizations (1988) (8)
Devising prevention and treatment strategies for the nation's diverse populations with mental illness. (2007) (7)
A comparison between the growth hormone responses to amphetamine and clonidine (1985) (7)
Foreword. A revolution in cognitive neuroscience. (2011) (7)
The prescriber's guide to classic MAO-inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. (2022) (7)
Oxytocin and the neuroendocrine basis of affiliation. (1993) (6)
Implications for the Neurobiology of Love (2002) (6)
Activation of c fos like protein in pvn oxytocin cells during male sexual behavior (1991) (6)
Neuroscience: Shining a light on depression (2011) (5)
Lithium and mood change in affective disorder patients. (1981) (5)
Translational research in the decade of discovery (2006) (5)
Serotonin in obsessive-compulsive disorder: a causal connection or more monomania about a major monoamine? (1991) (5)
Rearing paradigm in a nonhuman primate affects response to beta-CCE challenge. (1988) (5)
Toward Precision Medicine in Psychiatry (2013) (5)
Diagnosis and Treatment of Obsessive-Compulsive Disorder (1988) (4)
Components of the Economic Burden of Serious Mental Illness in the US (2009) (4)
Benzodiazepine receptor-mediated experimental ‘anxiety’ in rhesus monkeys after infusion of 3-carboethoxy-ß-carboline (ß-CCE) (1983) (4)
Rearing paradigm in a nonhuman primate affects response to β-CCE challenge (2006) (4)
Harnessing the informatics revolution for neuroscience drug R&D (2014) (4)
Integrating neuroscience into psychiatric residency training. (2015) (4)
Acute and chronic effects of desipramine administration to rhesus monkeys. (1987) (4)
New pharmacologic approaches to obsessive compulsive disorder. (1990) (4)
New drug development for cognitive enhancement in mental health: Challenges and opportunities (2013) (4)
Standardization, Integration, and Sharing—Leveraging Research Investments (2011) (4)
The Neurobiology of Anxiety: A Tale of Two Systems (1986) (4)
Models of Mental Disorders: A New Comparative Psychiatry (1990) (3)
Special issue on anorexia nervosa (2005) (3)
Compassionate allowance for people with schizophrenia? (2012) (3)
RAISE-ing Our Expectations for First-Episode Psychosis. (2016) (3)
Harnessing the informatics revolution for neuroscience drug R&D (2014) (3)
Mental health care 2.0. (2022) (3)
A different way of thinking (2015) (3)
Tribute to Wayne Fenton, MD (1953–2006) (2006) (3)
From Inconvenient Truth to Urgent Opportunity (2013) (2)
Foreword for inaugural issue of Journal of Neurodevelopmental Disorders (2009) (2)
Precision Medicine for Mental Disorders (2015) (2)
Phenotypic expression of an oxytocin peptide null mutation in mice. (1998) (2)
Animal Research in Psychiatry and Neurology (1999) (2)
Has OCD research gone to the dogs? Comments on "Recent advances in obsessive-compulsive disorder". (1991) (2)
Response to: "Rescuing the NIH before it is too late". (2006) (2)
The monogamous Brain: Or , what midweatern rodent has taught us about the chemistry of mammalian love (1995) (2)
Research funding: the view from NIH. (2006) (2)
Harnessing the Innate Plasticity of the Brain for Recovery (2014) (2)
Rethinking Mental Disorders: How Research Will Change Clinical Practice (2008) (2)
Emerging ideas in brain science (2009) (2)
Technology as a Tool for Mental Disorders-Reply. (2018) (2)
Prologue: Expression Profiling Within the Central Nervous System, Part II (2004) (1)
Special issue on diagnosis and classification (2007) (1)
Reconceptualizing Schizophrenia (2011) (1)
AIDS: A Cautionary Tale (2014) (1)
The Importance of a Clinical Perspective-Reply (1984) (1)
SPONTANEOUS PROSTATE CANCER IN A SQUIRREL MONKEY (1999) (1)
Wayne Fenton, M.D. (2008) (1)
What's so special about development? (2000) (1)
BIOLOGIC MARKERS FOR SEROTONERGIC DYSFUNCTION IN PSYCHIATRIC DISORDERS (1984) (1)
Behavioral Research at NIMH Reorganizing the 'Bricks' to Advance Public Health. (2005) (1)
Correction: The AURORA Study: a longitudinal, multimodal library of brain biology and function after traumatic stress exposure (2020) (1)
3. Will Technology Transform Mental Health Care? (2017) (1)
New Hope for Treating Psychosis (2015) (1)
A conversation with Thomas R. Insel, MD. (2012) (1)
Commentary on "The Need for Patient-Subjective Data in the (2010) (1)
Research on Major Depression (2017) (1)
Convergence Science: Shaping 21st Century Psychiatry (2015) (1)
Pituitary-adrenal activity following inescapable shock-effects of dexamethasone (1987) (1)
[Relationship of psychiatrists to the pharmaceutical companies--part of, or the solution to, the problem]. (2010) (0)
Advances in obsessive-compulsive disorder research. (1981) (0)
Speaking of Psychology: Smartphones Are a Problem: Can They Be a Solution?: (501062019-001) (2018) (0)
Abnormalities in the primary affective disorders compared to other tricyclic-responsive disorders. (1983) (0)
New approaches to the neurobiology of autism (1998) (0)
Public health contributions. (2007) (0)
Biological Classification of Mental Illness (2011) (0)
The Paradox of Parity (2014) (0)
Commentary: Public Health Contributions (2007) (0)
Subject Index Vol. 44, 1986 (1986) (0)
Dr. Insel and Colleagues Reply (2007) (0)
Social neuroscience: from genes to social behavior (2006) (0)
AI and the New Medicine (2019) (0)
Transgenic Models for Oxytocin and Vasopressin (2001) (0)
Thomas Insel: how to get your own slice of the mandala. (2008) (0)
Hormones and Behavior--Revisited. (1991) (0)
The next generation of therapeutics: where, when, how? (2013) (0)
What cell biologists should know about the National Institutes of Health BRAIN Initiative (2015) (0)
Experimental analysis of the DST and pituitary-dependent opiate analgesia in the learned helplessness paradigm (1991) (0)
Depression, Daughters, and Cellular Aging (2015) (0)
Report of Two Cases (1983) (0)
Role of Hydroxylase Cofactor in Regulating Dopamine Synthesis: Relevance to Neurological Disorders (1986) (0)
What Caused This to Happen (2015) (0)
NIMH's Top 10 Research Advances of 2011 (2011) (0)
Time 100 scientists & thinkers. Paul Allen. (2008) (0)
Report from the National Institute of Mental Health (2005) (0)
The benzodiazepine-GABA receptor system and social attachment (1987) (0)
Wayne Fenton, 1953–2006 (2007) (0)
CME Monograph Tests (1984) (0)
Behavioral Research at NIMH (2005) (0)
RAT PUP ISOLATION CALLS: A POTENTIAL SCREEN FOR ANXIOLYTICS (1992) (0)
Ensuring public trust (2004) (0)
Gene Discovery and the Future of Psychiatry (2000) (0)
Sponsors' Foreword (2004) (0)
Contents, Vol. 17, Supplement 1, 1984 (1984) (0)
Foreword (2011) (0)
How algorithms could bring empathy back to medicine (2019) (0)

This paper list is powered by the following services:

Other Resources About Thomas R. Insel

en.wikipedia.org

What Schools Are Affiliated With Thomas R. Insel?

Thomas R. Insel is affiliated with the following schools:

Image Attributions

Image Source for Thomas R. Insel